Netherlands· NL-490e83ee60ce

Atomoxetine Amarox 10 mg, harde capsules

A atomoxetine product containing atomoxetinehydrochloride, registered in Netherlands by Amarox Pharma B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC N06BA09

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about atomoxetinehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Atomoxetine is registered in 17 of 19 countries.

Countries holding a registration under ATC N06BA09 (atomoxetine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search atomoxetine products by name

Atomoxetine · ATC N06BA09

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of atomoxetine costs, country by country.

Normalised to the WHO defined daily dose (80 mg), the median price runs from $1.05 in United States to $9.70 in Switzerland — a ×9.2 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Atomoxetine · price per daily dose (80 mg)

USD · FX 28 Sept 2026

CH Switzerland$9.70
ES Spain$2.37
US United States$1.05 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ATOMOXETINEHYDROCHLORIDE
Manufacturer: Amarox Pharma B.V.
Country: Netherlands (NL)
ATC code: N06BA09
ATC class: Atomoxetine
Defined daily dose: 80 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
130359

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

275 interactions on record for atomoxetine.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check atomoxetine against other medicines How interaction checks work

Atomoxetine · interactions on record

275 records

50 severe
166 moderate
4 minor
54 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
PapaverinC04AX38severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Atomoxetine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All atomoxetine products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

Austria · Atofab, Atomoxetin Amarox
Belgium · Strattera
Bulgaria · Atofab
Cyprus · Strattera
Czechia · Atofab, Atominex
Germany · Agakalin, Atama
Denmark · Atomoxetin Amarox, Atomoxetin Glenmark
Estonia · Atominex
Spain · Atamax, Atomoxetina Aurovitas
Finland · Atomoxetin Orion, Atomoxetine Accord
United Kingdom (Northern Ireland) · Atomaid, Atomoxetine
Greece · Atama
Croatia · Attoxem
Hungary · Atomoxetin Amarox, Bitinex
Ireland · Atomoxetine Accord, Atomoxetine Azure
Iceland · Atomoxetin Actavis, Atomoxetin Medical Valley
Malta · Atomoxetina Generis, Atomoxetine Aurobindo
Norway · Atomoxetin Orion, Atomoxetine Accord
Poland · Atomoksetyna Medice, Auroxetyn
Portugal · Atomoxetina Generis, Atomoxetina Macleods
Romania · Atofab, Atomoxetin Accord
Sweden · Atomoxetin Actavis, Atomoxetin Amarox
Slovenia · Atomoksetin Accord, Strattera
Slovakia · Atofab, Atominex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c3f6aba8-9315-41d1-962a-c60d7fd0e88f
GET /v1/drugs/c3f6aba8-9315-41d1-962a-c60d7fd0e88f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h130359_smpc.pdf",
  "strength": null,
  "atc_label": "Atomoxetine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130359",
  "excipients": [
    "AMMONIA (E 527)",
    "DIMETICON (E 900)",
    "GELATINE (E 441)",
    "IJZEROXIDE ZWART (E 172)",
    "KALIUMHYDROXIDE (E 525)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "NATRIUMLAURILSULFAAT",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "ATOMOXETINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130359.pdf",
  "authorised_at": "2024/03/06",
  "procedure_number": "DE/H/7606/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "130359",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about atomoxetine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console